Elias Zerhouni

Dr. Elias A. Zerhouni, MD, is a Chairman at Boston Pharmaceuticals, Inc., a Vice Chairman & President at OPKO Health, Inc., an Independent Director at Danaher Corp., a Member at National Academy of Engineering, a Member at National Academy of Medicine (United States) and a Professor at The Johns Hopkins University.
He is on the Board of Directors at OPKO Health, Inc., B-Flexion Capital Holdings (Jersey) Ltd., Danaher Corp., Research!America, King Abdullah University of Science & Technology, Lasker Foundation, Mayo Clinic and Mayo Foundation for Medical Education & Research.
Dr. Zerhouni was previously employed as a Chairman by ModeX Therapeutics, Inc., a Member by Académie Nationale de Médecine FCP, a President-Global Research & Development by Sanofi, a Trustee-Emeritus by The Mayo Clinic (Old), a Chairman & President by The Zerhouni Group LLC, a Chairman & President by Zerhouni Holdings, Inc., a Chairman-Russell H.
Morgan Department by The Johns Hopkins Health System Corp., a Vice Dean & Professor by The Johns Hopkins University School of Medicine, a Co-Founder by Computerized Imaging Reference Systems, Inc., and a Chairman-Innovation by College de France.
He also served on the board at Actelion Ltd., National Institutes of Health, Mayo Medical Ventures and Warp Drive Bio, Inc. He received his doctorate degree from The University of Algiers.